查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840701

青光眼手术器械市场（按手术方式、器械、最终用户和分销管道划分）－全球预测，2025-2032年

Glaucoma Surgery Devices Market by Procedure, Device, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，青光眼手术器械市场将成长至 16.5457 亿美元，复合年增长率为 7.23%。

关键市场统计数据
基准年 2024 9.4593亿美元
预计年份：2025年 1,013,250,000 美元
预测年份 2032 1,654,570,000 美元
复合年增长率 (%) 7.23%

本书重点介绍青光眼手术器械领域中影响现代决策的临床需求、器械类型、治疗环境和通路。

青光眼仍然是导致不可逆性视力丧失的主要原因之一，而手术干预的临床和商业性格局正因人口结构变化、监管政策发展和技术进步而迅速演变。在此背景下，一篇简明扼要的介绍必须从临床需求、器械创新和不断演变的治疗路径的相互作用出发，阐述当前青光眼治疗的现状，这些因素都会影响临床医生的选择和患者的治疗结果。

从历史上看，青光眼引流植入、小梁切除术和引流管植入等传统手术方法一直是晚期青光眼手术治疗的基石。同时，iStent、Kahook双刃刀、Trabectome和XEN凝胶支架等微创手术方法拓展了早期青光眼以及白内障联合青光眼手术的治疗选择。这些技术上的差异体现在器械类型上，包括雷射设备（分为氩雷射和选择性雷射）；引流装置（如Ahmed阀、Baerveldt植入和Molteno植入）；支架（如Hydrus微支架、iStent和XEN凝胶支架）；以及手术刀片（以Kahook双刃刀和Trabectome平台为代表）。

门诊手术中心、医院和眼科诊所的手术量、报销趋势和资本购置模式各不相同，这些因素都会影响其采购决策。分销管道，包括直销、线上销售和第三方分销商，进一步决定了医疗器材如何到达临床医生手中，以及製造商如何拓展其地理覆盖范围。这些因素有助于读者建构理解以下章节的框架，这些章节将探讨转型变革、贸易政策影响、市场区隔细微差别、区域差异化因素、竞争策略以及为产业领导者提供的实用建议。

临床重点、设备创新和采购管道转变如何共同作用，重新定义青光眼手术的治疗流程和竞争格局

青光眼手术器材领域正经历一系列变革时期，这些变革正在重新定义临床诊疗流程、采购惯例方式和创新重点。临床上，人们明显倾向于选择併发症率更低、恢復时间更短且能与白内障手术相容的手术方式。因此，越来越多的临床医生正在权衡传统手术方法（如青光眼引流植入植入、小梁切除术和引流管植入术）的长期有效性，以及微创手术（如iStent、Kahook双刃刀、Trabectome和XEN凝胶支架）的便利性和良好的围手术全期安全性。

随着雷射技术分化为针对特定组织相互作用的氩雷射和选择性模式，以及支架和分流器设计不断迭代以提高生物相容性、流量控制和植入重复性，包括雷射设备、分流器、支架和手术刀片在内的器械细分正在从独立的产品线转向一体化的手术生态系统。

同时，供应和商业化模式也在不断演变。门诊手术中心、医院和眼科诊所各自拥有不同的奖励机制，这影响着它们对直销关係、线上采购或依赖第三方经销商的选择。监管监督和报销政策的调整迫使製造商优先考虑实证医学证据的开发和真实世界疗效，从而加速那些能够展现临床和经济价值的产品的推广应用。总而言之，这些趋势正在创造一个更加多元化的市场环境，多种方法并存，竞争日益以创新主导，而市场准入既需要临床信誉，也需要稳健的市场进入策略。

2025年关税实施后供应链的重组及其对製造和分销网络运营、商业和采购的影响

2025年关税的实施为眼科手术器械的全球供应链和定价策略带来了新的复杂性。依赖跨境供应链采购关键零件和成品的製造商面临投入成本的增加，这往往迫使他们重新评估其生产布局、供应商合约和产品定价策略。为了应对这项挑战，一些公司加快了关键生产流程的在地化进程或实现了供应商多元化，以降低风险；而另一些公司则选择承受暂时的成本上涨，以维持市场进入和与临床医生的关係。

这些调整对分销管道和终端用户产生了连锁反应。门诊手术中心、医院和眼科诊所对价格的敏感度各不相同，取决于其报销环境和采购模式。在直销模式占主导地位的地区，製造商与采购团队紧密合作，调整定价、捆绑销售和服务协议。在第三方分销仍然占据重要地位的地区，经销商不得不重新谈判条款并管理库存策略，以最大限度地减少利润压缩。

在营运方面，关税的取消促使人们在评估医疗器材时重新专注于服务成本分析和总拥有成本 (TCO)。製造商更加重视营运效率、供应链透明度和售后支持，以支撑其定价策略。同时，政策环境凸显了区域製造能力和灵活的分销网络对于保持韧性并响应临床医生需求的重要性。整体而言，关税主导的动态正在加速采取务实的短期措施来稳定供应，同时也促使医疗设备的生产和供应方式发生长期策略转变。

主导的观点将手术类型、医疗设备类别、医疗机构和分销管道联繫起来，揭示了目标明确的采用路径和市场定位机会。

多维度的市场细分方法揭示了手术流程、器械、终端用户和分销管道等方面的明确成长要素和推广障碍。依手术流程划分，市场可分为传统手术和微创手术。由于青光眼引流植入、小梁切除术和引流管植入术等成熟技术的应用，传统手术在治疗晚期疾病方面仍具有临床优势。微创手术，包括iStent、Kahook Dual Blade、Trabectome和XEN Gel Stent等平台，因其良好的安全性和恢復性，越来越多地应用于轻度至中度青光眼患者以及白内障和青光眼联合手术。

这些器械包括雷射装置、引流管、支架和手术刀片。雷射技术分为氩雷射和选择性雷射，分别针对不同的组织标靶和手术目标。引流管，例如Ahmed阀、Baerveldt植入和Molteno植入，仍是难治性青光眼治疗的主要手段。支架技术，例如Hydrus微支架、iStent和XEN凝胶支架，代表了微创房水引流增强技术的创新，而手术刀片系统，例如Kahook双刃刀和Trabectome，则支援具有不同学习曲线和术中操作特点的组织消融策略。

终端使用者细分凸显了门诊手术中心、医院和眼科诊所各自独特的应用环境，这些环境与病例组合、资本规划週期和医疗服务模式密切相关。销售管道细分——包括直销、线上销售和第三方分销商——阐明了製造商必须如何调整其销售团队策略、数位化通路和经销商伙伴关係，以确保产品供应、临床医生培训和售后支援。将产品创新与这些细分维度进行匹配，有助于相关人员确定临床需求和商业机会的契合点，以及如何透过有针对性的证据产生来最有效地推动产品应用。

美洲、欧洲、中东和非洲以及亚太地区之间的战略差异将决定商业化、证据和供应策略的差异性。

区域动态对医疗设备策略、报销谈判和商业化策略的发展至关重要，而独特的区域特征则造就了不同的推广路径。美洲地区拥有复杂的公私支付方组合、高密度的门诊手术中心、临床医生在技术应用方面拥有高度自主权以及明确的报销机制，这些因素都促进了成熟和新型外科手术解决方案的快速普及。

欧洲、中东和非洲的监管和报销环境各不相同，这要求製造商采取区域性实证策略并儘早与支付方接洽。该区域内各国在卓越中心（COE）模式、医院采购惯例和成本效益优先事项方面存在显着差异，这会影响产品上市顺序以及为支持更广泛的市场准入而需要开展的上市后监测范围。

亚太地区拥有广泛的需求驱动因素，包括新兴经济体人口老化、手术量增加、产能扩张等。各地区的生产和监管路径，以及不同的临床医师训练体系，都会影响新型微创技术融入常规诊疗的速度。在所有地区，分销管道动态和关税相关因素与当地监管压力相互交织，共同决定产品的上市时间、定价策略以及与临床医生的合作计划。

强调临床证据、整合服务模式和供应链韧性的竞争策略如何重塑公司差异化和伙伴关係活动

青光眼手术器材领域的竞争体现在对产品改进、策略伙伴关係、实证医学证据累积和临床医生培训的投入。市场参与企业正致力于提升器械性能，以提高植入物的可重复性、耐用性和安全性，同时也在建构相关服务，以减轻手术团队的营运负担。

一些公司优先考虑整合价值提案，将器械供应与手术培训、数位化支援工具和患者追踪平台相结合，以展现实际疗效和成本效益优势。另一些公司则专注于地理扩张，透过加强与分销商的关係或建立区域性生产来缩短前置作业时间并减轻关税负担。器械创新者与成熟的外科公司之间的合作日益普遍，这既能快速扩大市场覆盖范围，又能充分利用现有的销售和培训基础设施。

这些措施的通用在于强调临床证据和上市后监测，以增强支付方的参与度和临床医生的信心。那些将研发重点与明确的最终用户需求（例如，医院采购动态、门诊手术中心的工作流程、眼科诊所的限制）相结合的公司，往往能够实现更连贯的市场推广路径。最终，竞争优势不再仅取决于产品特性，还取决于能否提供可重复的临床结果、简化培训流程以及确保供应链的可靠性。

对于製造商和相关人员，这是一个清晰、务实的策略倡议，有助于加强证据支持、提升供应链灵活性、建立差异化商业模式，并推动持久应用。

产业领导者应优先考虑一系列切实可行的倡议，以充分利用当前趋势，同时降低营运和商业风险。首先，透过将临床开发与真实世界证据的优先事项结合，加快支付方参与和临床医生采纳。有针对性的临床项目应重点关注对外科医生和支付方都至关重要的安全性和生活品质终点。其次，透过生产和供应基地多元化，并儘可能采用近岸外包，可以减轻关税引起的成本波动的影响，并提高对区域需求的应对力。

第三，製造商应投资量身定制的打入市场策略，以反映门诊手术中心、医院和眼科诊所之间的差异，并针对每种环境调整培训、报销支援和服务模式。第四，销售策略应有意采用混合模式：在专科中心建立强大的直销关係，以增加接触点；同时辅以数位通路和第三方经销商，以扩大地域覆盖范围并提高效率。第五，企业应考虑透过将医疗设备与数位化追踪工具和管理服务捆绑销售来体现价值差异化，从而展现整体医疗成本效益。

最后，策略伙伴关係，例如共同开发、培训网络和区域商业化，可以在共用实施风险的同时加快产品普及。透过实用化这些建议，产业领导者可以製定稳健的商业化计划，使产品创新与实际应用路径和支付方预期相契合。

严谨的混合方法研究设计，结合临床医师访谈、系统性文献回顾和逻辑分析，将检验研究结果并找出限制。

本分析的调查方法融合了定性和定量方法，旨在确保其稳健性、偏好和对临床医生的相关性。主要研究包括对来自门诊手术中心、医院和眼科诊所的外科医生、采购负责人和临床负责人进行结构化访谈，以了解他们的手术偏好、器械选择标准和术后管理实践。

二次研究包括对同行评审的临床文献、监管申报文件、器械标籤和行业出版刊物进行系统性回顾，以揭示雷射器械、分流器、支架和手术刀片的技术发展。透过交叉检验，结合主要受访者的见解和二手讯息，对数据进行三角验证，以减少偏差并识别一致的模式。应用分割映射法，将手术类别（例如传统手术和微创手术）与器械原型和最终用户行为相匹配。

分析方法包括对定性输入资料进行主题综合分析，以及对供应链和关税影响进行情境分析。品管包括清晰记录调查方法和资料来源，以确保调查方法的透明度。这种多层次的方法确保了结论既反映了前沿的临床实践，也反映了更广泛的技术和政策驱动因素。

简明扼要地总结了流程演进、设备差异化和策略要务之间的关係，从而指明了产品推广应用和永续商业性成功的路径。

总之，青光眼手术器械领域是由临床发展、技术差异化和商业性适应症三者之间复杂的相互作用所决定的。虽然传统手术方法在治疗晚期疾病方面仍然发挥着至关重要的作用，但微创手术正在再形成早期介入策略和手术全期管理。这些手术方式的演变也体现在器械的细分上，包括雷射器械、引流管、支架和手术刀片，每种器械都有其不同的临床应用依据和推广应用的挑战。

区域和政策发展，包括与关税相关的供应链调整，凸显了製造弹性、分销敏捷性和主导商业化的重要性。终端使用者——门诊手术中心、医院和眼科诊所——正在寻求能够满足自身需求的合约模式，以反映其手术组合、采购週期和培训需求。竞争优势的差异化不仅取决于产品属性，还取决于经实践验证的疗效、可重复的植入技术以及综合支援服务。

展望未来，能够将有针对性的临床证据产生、稳健的供应链策略和精细化的市场推广执行相结合的相关人员，将更有能力把创新转化为持续的临床应用和商业性成功。这种整合为规划后续步骤（包括产品开发、市场进入和组织投资）奠定了实际的基础。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 微创青光眼手术植入（具有药物释放型功能，可降低眼内压）的应用日益普及
  • 开发一种具有可调节管腔直径的微型支架设计，用于个体化眼内压管理
  • 整合即时术中影像导引系统，以提高手术精确度和安全性
  • 用于控制术后发炎的新型缓释眼科药物传递平台
  • 人们对用于远端患者管理的远端眼内压监测植入越来越感兴趣
  • 可生物降解的微创青光眼手术植入取得进展，可最大限度减少长期併发症
  • 医疗器材製造商与人工智慧公司合作，预测青光眼进展并优化手术时机
  • 加大对用于同时治疗白内障和青光眼的联合手术设备的投入
  • 新一代小梁网旁路植入物已获得监管部门核准，植入具有更佳的生物相容性和长期通畅性

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 青光眼手术器械市场（依手术类型划分）

  • 传统手术
    • 青光眼引流植入植入
    • 切除术
    • 分流管
  • 微创手术
    • IStent
    • 卡胡克双刃
    • 横纹肌瘤
    • XEN凝胶支架

9. 青光眼手术器械市场（依器械类型划分）

  • 雷射元件
    • 氩雷射器
    • 选择性雷射
  • 分流
    • 艾哈迈德·巴尔布
    • 巴雷费尔特植入
    • 莫尔特诺植入
  • 支架
    • Hydrus 微支架
    • IStent
    • XEN凝胶支架
  • 手术刀片
    • 卡胡克双刃
    • 曲安奈德装置

第十章 青光眼手术器械市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 眼科诊所

第十一章 青光眼手术器械市场（依通路划分）

  • 直销
  • 线上销售
  • 第三方经销商

12. 各地区青光眼手术器材市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 青光眼手术器械市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国青光眼手术器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Alcon Inc.
    • Bausch & Lomb Incorporated
    • AbbVie Inc.
    • Carl Zeiss Meditec AG
    • Santen Pharmaceutical Co., Ltd.
    • Glaukos Corporation
    • Nidek Co., Ltd.
    • Topcon Corporation
    • Ellex Medical Lasers Limited
    • New World Medical, Inc.
Product Code: MRR-A339DAEF9D8F

The Glaucoma Surgery Devices Market is projected to grow by USD 1,654.57 million at a CAGR of 7.23% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 945.93 million
Estimated Year [2025] USD 1,013.25 million
Forecast Year [2032] USD 1,654.57 million
CAGR (%) 7.23%

A focused introduction that frames clinical need, device typologies, care settings, and distribution pathways driving contemporary decision-making in glaucoma surgery devices

Glaucoma remains a leading cause of irreversible vision loss, and the clinical and commercial environment for surgical interventions has evolved rapidly in response to demographic pressures, regulatory developments, and technological advances. In this context, a concise introduction must frame the current landscape through the interplay of clinical need, device innovation, and evolving care pathways that influence clinician choice and patient outcomes.

Historically, conventional surgery approaches such as glaucoma drainage implants, trabeculectomy, and tube shunts have formed the backbone of surgical management for advanced disease, while microinvasive surgery options like iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent have expanded treatment options for earlier-stage disease and combined cataract-glaucoma procedures. These procedural distinctions are mirrored by device typologies that include laser devices subdivided into argon and selective laser modalities, shunts encompassing Ahmed valve, Baerveldt implant, and Molteno implant variants, stents such as Hydrus Microstent, iStent, and XEN Gel Stent, and surgical blades represented by Kahook Dual Blade and Trabectome platforms.

End-user dynamics also shape adoption patterns: ambulatory surgery centers, hospitals, and ophthalmic clinics each present different procedural volumes, reimbursement dynamics, and capital-acquisition models that influence procurement decisions. Distribution channels-including direct sales, online sales, and third-party distributors-further determine how devices reach clinicians and how manufacturers scale geographic coverage. Together, these elements establish the frame for readers to understand the subsequent sections, which examine transformative shifts, trade policy impacts, segmentation nuances, regional differentiators, competitive behaviors, and practical recommendations for industry leaders.

How clinical priorities, device innovation, and shifting procurement channels are converging to redefine treatment algorithms and commercial competition in glaucoma surgery

The landscape for glaucoma surgery devices is undergoing a series of transformative shifts that are redefining clinical algorithms, procurement practices, and innovation priorities. Clinically, there is a clear movement toward procedures that promise lower complication rates, faster recovery times, and compatibility with combined cataract procedures. As a result, clinicians are increasingly balancing the long-established efficacy of conventional surgery approaches such as glaucoma drainage implants, trabeculectomy, and tube shunts against the procedural simplicity and favorable perioperative profiles of microinvasive surgery options like iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent.

Technological advances are not limited to device miniaturization: laser technologies are differentiating into argon and selective modalities that target specific tissue interactions, while stent and shunt designs are iterating to improve biocompatibility, flow regulation, and implantation reproducibility. Device segmentation that includes laser devices, shunts, stents, and surgical blades is therefore shifting from discrete product families to integrated procedural ecosystems, where device choice is driven as much by system compatibility and surgeon preference as by clinical indication.

Meanwhile, delivery and commercialization models are evolving. Ambulatory surgery centers, hospitals, and ophthalmic clinics exhibit different incentive structures, influencing choice of direct sales relationships, online procurement options, or reliance on third-party distributors. Regulatory scrutiny and reimbursement policy adjustments are prompting manufacturers to prioritize evidence development and real-world outcomes, accelerating adoption pathways where clinical and economic value can be demonstrated. Taken together, these trends are creating a more pluralistic market environment in which multiple approaches coexist, competition is increasingly innovation-led, and market entry requires both clinical credibility and robust commercialization strategy.

The 2025 tariff-driven supply-chain recalibration and its operational, commercial, and procurement implications across manufacturing and distribution networks

The introduction of tariffs in 2025 introduced a new layer of complexity for global supply chains and pricing strategies for ophthalmic surgical devices. Manufacturers that source key components or finished devices from cross-border supply chains have faced increased input costs that, in many cases, require reassessment of manufacturing footprints, supplier contracts, and product pricing strategies. In response, some companies have accelerated localization of critical manufacturing steps or diversified suppliers to mitigate exposure, while others have absorbed incremental costs temporarily to preserve market access and clinician relationships.

These adjustments have had ripple effects across distribution channels and end users. Ambulatory surgery centers, hospitals, and ophthalmic clinics have experienced varying degrees of price sensitivity depending on their reimbursement environments and purchasing models. Where direct sales models predominate, manufacturers have worked closely with procurement teams to tailor pricing, bundling, or service agreements. Where third-party distribution remains important, distributors have had to renegotiate terms and manage inventory strategies to minimize margin compression.

Operationally, tariffs have encouraged a renewed focus on cost-to-serve analyses and total cost of ownership when evaluating devices. Manufacturers are placing higher emphasis on operational efficiency, supply-chain transparency, and post-market support that can justify price positions. At the same time, the policy environment has underscored the strategic importance of regional manufacturing capacities and flexible distribution networks to maintain resilience and responsiveness to clinician demand. Overall, the tariff-driven dynamics have accelerated pragmatic, near-term actions to stabilize supply, while prompting longer-term strategic shifts in where and how devices are produced and delivered.

A granular segmentation-driven perspective linking procedural types, device categories, care settings, and distribution channels to reveal targeted adoption pathways and positioning opportunities

Segmentation provides the scaffolding for nuanced analysis and market positioning, and a multifaceted segmentation approach reveals distinct growth levers and adoption barriers across procedure, device, end user, and distribution channels. Based on procedure, the market divides into conventional surgery and microinvasive surgery. Conventional surgery retains clinical primacy for advanced disease with established techniques such as glaucoma drainage implants, trabeculectomy, and tube shunts. Microinvasive surgery, which includes platforms such as iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent, is increasingly positioned for patients with mild to moderate disease or for combined cataract-glaucoma procedures because of favorable safety and recovery profiles.

From a device perspective, the landscape encompasses laser devices, shunts, stents, and surgical blades. Laser technologies bifurcate into argon and selective laser approaches that serve different tissue targets and procedural intents. Shunt solutions, including Ahmed valve, Baerveldt implant, and Molteno implant variants, continue to be central to management of refractory glaucoma. Stent technologies such as Hydrus Microstent, iStent, and XEN Gel Stent reflect innovation in minimally invasive outflow augmentation, while surgical blade systems like Kahook Dual Blade and Trabectome devices support tissue resection strategies with different learning curves and intraoperative profiles.

End-user segmentation highlights that ambulatory surgery centers, hospitals, and ophthalmic clinics each present unique adoption environments tied to case mix, capital planning cycles, and care delivery models. Distribution channel segmentation-direct sales, online sales, and third-party distributors-reveals how manufacturers must harmonize sales force strategies, digital channels, and distributor partnerships to ensure product availability, clinician training, and after-sales support. By mapping product innovation to these segmentation axes, stakeholders can identify where clinical needs align with commercial opportunity and where targeted evidence generation will most effectively drive adoption.

Regional strategic differentials across the Americas, Europe, Middle East & Africa, and Asia-Pacific that dictate tailored commercialization, evidence, and supply strategies

Regional dynamics are instrumental in shaping device strategy, reimbursement interactions, and commercialization tactics, and distinct regional characteristics create differentiated pathways to adoption. The Americas exhibit a complex mix of private and public payers, robust ambulatory surgery center activity, and a high degree of clinician autonomy in technology adoption, which together encourage rapid uptake of both established and novel surgical solutions where reimbursement clarity exists.

Europe, Middle East & Africa feature heterogeneous regulatory and reimbursement environments that compel manufacturers to adopt localized evidence strategies and engage payers early. Countries within this region vary considerably in their center-of-excellence models, hospital procurement practices, and emphasis on cost-effectiveness, which affects the sequencing of product launches and the scope of post-market studies required to support broader access.

Asia-Pacific presents a wide spectrum of demand drivers, from aging populations in developed economies to rising procedural volumes and capacity expansion in emerging markets. Local manufacturing and regulatory pathways, along with differing clinician training infrastructures, influence how quickly newer microinvasive technologies are integrated into standard practice. Across all regions, distribution channel dynamics and tariff-related considerations intersect with regional regulatory pressures to shape launch timing, pricing strategies, and clinician engagement plans.

How competitive strategies emphasizing clinical evidence, integrated service models, and supply-chain resilience are reshaping company differentiation and partnership activity

Competitive behavior among companies in the glaucoma surgery devices space reflects a mix of incremental product refinement, strategic partnerships, and investments in evidence generation and clinician training. Market participants are channeling resources toward device improvements that address implantation reproducibility, durability, and safety profiles, while simultaneously building services that reduce the operational burden on surgical teams.

Some firms are prioritizing integrated value propositions that combine device supply with procedural training, digital support tools, and patient follow-up platforms to demonstrate real-world outcomes and cost-to-serve advantages. Others are focusing on geographic expansion by strengthening distributor relationships or establishing regional manufacturing to reduce lead times and tariff exposure. Collaborations between device innovators and established surgical companies are becoming more common as a means to scale access quickly while leveraging established sales and training infrastructures.

Across these behaviors, the common thread is an emphasis on clinical evidence and post-market surveillance to support payer engagement and clinician confidence. Companies that align R&D priorities with clear end-user needs-hospital procurement dynamics, ambulatory surgery center workflows, or ophthalmic clinic constraints-tend to achieve more coherent adoption trajectories. Ultimately, competitive differentiation is increasingly defined by the ability to offer reproducible clinical outcomes, streamlined training, and supply-chain reliability rather than by product features alone.

Clear, practical strategic moves for manufacturers and stakeholders to strengthen evidence, supply agility, and differentiated commercial models that drive durable adoption

Industry leaders should prioritize a set of actionable initiatives to capitalize on current trends while mitigating operational and commercial risks. First, aligning clinical development with real-world evidence priorities will accelerate payer engagement and clinician uptake; targeted clinical programs should emphasize comparative safety and quality-of-life endpoints that matter to both surgeons and payers. Second, diversifying manufacturing and supplier bases-paired with nearshoring where feasible-will reduce exposure to tariff-driven cost volatility and improve responsiveness to regional demand.

Third, manufacturers should invest in tailored go-to-market strategies that reflect differences across ambulatory surgery centers, hospitals, and ophthalmic clinics, ensuring that training, reimbursement support, and service models are adapted to each setting. Fourth, distribution strategies must be deliberately hybrid: robust direct-sales relationships in high-touch specialty centers, complemented by digital channels and third-party distributors for broader geographic coverage and efficiency gains. Fifth, companies should consider bundling devices with digital follow-up tools or managed services to demonstrate total cost of care benefits and differentiate on value.

Finally, forging strategic partnerships-whether for co-development, training networks, or regional commercialization-can accelerate access while sharing implementation risk. By operationalizing these recommendations, industry leaders can build resilient commercialization plans that align product innovation with practical adoption pathways and payer expectations.

A rigorous mixed-methods research design combining clinician interviews, systematic literature review, and triangulated analysis to validate findings and highlight limitations

The research methodology underpinning this analysis integrates qualitative and quantitative approaches designed to ensure robustness, reliability, and practitioner relevance. Primary research included structured interviews with surgeons, procurement officers, and clinical leaders across ambulatory surgery centers, hospitals, and ophthalmic clinics to capture procedural preferences, device selection criteria, and post-operative management practices.

Secondary research involved systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and industry publications to contextualize technological developments across laser devices, shunts, stents, and surgical blades. Data were triangulated through cross-validation between primary respondent insights and secondary sources to reduce bias and identify consistent patterns. Segmentation mapping was applied to align procedural categories such as conventional surgery and microinvasive surgery with device archetypes and end-user behaviors.

Analytical techniques included thematic synthesis for qualitative inputs and scenario analysis for supply-chain and tariff impacts. Quality controls included respondent validation, where key findings were reviewed with a subset of interviewees for accuracy, and methodological transparency, with clear documentation of data sources, inclusion criteria, and any limitations. This layered approach ensured that conclusions reflect both frontline clinical practice and broader technology and policy dynamics.

A concise synthesis linking procedural evolution, device differentiation, and strategic imperatives that together define pathways to adoption and sustainable commercial success

In conclusion, the glaucoma surgery devices landscape is defined by a complex interplay of clinical evolution, technological differentiation, and commercial adaptation. Conventional surgical approaches maintain an indispensable role for advanced disease, while microinvasive options are reshaping earlier intervention strategies and perioperative management. These procedural dynamics are mirrored by device segmentation across laser devices, shunts, stents, and surgical blades, each with distinct clinical rationales and adoption challenges.

Regional and policy developments, including tariff-related supply-chain adjustments, have underscored the importance of manufacturing flexibility, distribution agility, and evidence-led commercialization. End users-ambulatory surgery centers, hospitals, and ophthalmic clinics-each demand tailored engagement models that reflect procedural mixes, procurement cycles, and training requirements. Competitive differentiation increasingly hinges on demonstrable real-world outcomes, reproducible implantation techniques, and integrated support services rather than product attributes alone.

Looking ahead, stakeholders that combine targeted clinical evidence generation, resilient supply-chain strategies, and nuanced go-to-market execution will be best positioned to convert innovation into sustained clinical adoption and commercial success. This synthesis provides a practical basis for planning next steps across product development, market entry, and organizational investments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of minimally invasive glaucoma surgery implants integrating drug-eluting capabilities to reduce intraocular pressure
  • 5.2. Development of micro-stent designs with adjustable lumen diameters for personalized intraocular pressure management
  • 5.3. Integration of real-time intraoperative imaging guidance systems to enhance surgical precision and safety
  • 5.4. Emergence of sustained release ocular drug delivery platforms for postoperative inflammation control
  • 5.5. Growing focus on telemetric intraocular pressure monitoring implants for remote patient management
  • 5.6. Advancements in biodegradable minimally invasive glaucoma surgery implants to minimize long-term complications
  • 5.7. Collaboration between device manufacturers and artificial intelligence firms to predict glaucoma progression and optimize surgical timing
  • 5.8. Increasing investment in combined cataract and glaucoma surgical devices for simultaneous dual pathology treatment
  • 5.9. Introduction of novel ab interno canaloplasty devices offering less invasive Schlemm's canal dilation without external incisions
  • 5.10. Regulatory approvals of next-generation trabecular meshwork bypass implants featuring enhanced biocompatibility and long-term patency

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glaucoma Surgery Devices Market, by Procedure

  • 8.1. Conventional Surgery
    • 8.1.1. Glaucoma Drainage Implants
    • 8.1.2. Trabeculectomy
    • 8.1.3. Tube Shunts
  • 8.2. Microinvasive Surgery
    • 8.2.1. IStent
    • 8.2.2. Kahook Dual Blade
    • 8.2.3. Trabectome
    • 8.2.4. XEN Gel Stent

9. Glaucoma Surgery Devices Market, by Device

  • 9.1. Laser Devices
    • 9.1.1. Argon Laser
    • 9.1.2. Selective Laser
  • 9.2. Shunts
    • 9.2.1. Ahmed Valve
    • 9.2.2. Baerveldt Implant
    • 9.2.3. Molteno Implant
  • 9.3. Stents
    • 9.3.1. Hydrus Microstent
    • 9.3.2. IStent
    • 9.3.3. XEN Gel Stent
  • 9.4. Surgical Blades
    • 9.4.1. Kahook Dual Blade
    • 9.4.2. Trabectome Device

10. Glaucoma Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Hospitals
  • 10.3. Ophthalmic Clinics

11. Glaucoma Surgery Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
  • 11.3. Third Party Distributors

12. Glaucoma Surgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glaucoma Surgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glaucoma Surgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Alcon Inc.
    • 15.3.2. Bausch & Lomb Incorporated
    • 15.3.3. AbbVie Inc.
    • 15.3.4. Carl Zeiss Meditec AG
    • 15.3.5. Santen Pharmaceutical Co., Ltd.
    • 15.3.6. Glaukos Corporation
    • 15.3.7. Nidek Co., Ltd.
    • 15.3.8. Topcon Corporation
    • 15.3.9. Ellex Medical Lasers Limited
    • 15.3.10. New World Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE GLAUCOMA SURGERY DEVICES MAR